MedPath

COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL

Not Applicable
Completed
Conditions
Rheumatic Diseases
Covid19
Interventions
Other: Questionnaire
Registration Number
NCT04542031
Lead Sponsor
The Royal Wolverhampton Hospitals NHS Trust
Brief Summary

The COVID-19 pandemic represents a threat to rheumatology patients. National advice for patients to 'shield' is based on risk stratification of therapies and other risk factors. While the epidemiology of COVID-19 in the rheumatological population is largely unknown large case registries are beginning to show potential drug treatment interactions. Strict self-isolation (shielding) has been recommended for those deemed 'high risk' although its impact on the likelihood of COVID-19 infection and health related quality of life (HRQoL) is unclear.

The study aims to explore how this unprecedented situation has impacted the Trust patients primarily evaluating prevalence of the infection, effect of stringent social distancing (shielding) and Quality of Life (QOL). This will be done via a voluntary questionnaire, sent via text messaging at 6 and 12 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1010
Inclusion Criteria
  • All rheumatology patients under active follow up at the Royal Wolverhampton Trust with a validated mobile telephone number
Exclusion Criteria
  • Patients without a validated mobile phone number linked to their hospital record

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SurveyQuestionnaireSurvey to be distributed at 6 and 12 months
Primary Outcome Measures
NameTimeMethod
Prevalence of COVID 191 year

percentage of cases

Mortality rates from COVID 191 year

number of deaths per 1000 individuals

Health related quality of life - Short Form 121 year

mental and physical component scores through patient reported outcomes. Normative score set at 50 with minimum score being 0 and maximum score being 100. Scores \>50 indicate better mental or physical health than the mean. Scores \<50 indicate worse mental or physical health than the mean

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Royal Wolverhampton NHS Trust

🇬🇧

Wolverhampton, West Midlands, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath